AEON Biopharma, Inc. (NASDAQ:AEON) filed a Form 8-K with the Securities and Exchange Commission on January 21, 2026, disclosing a material event.
AEON Biopharma, Inc.'s stock currently trades at $1.36 with a market capitalization of $9.0M. The Healthcare company's stock moved following the disclosure.